Ingkil, Jerlyn B.
HRN: 26-35-76 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/31/2025
CEFUROXIME 500MG (TAB)
01/31/2025
02/06/2025
PO
500mg
BID X 7 Days
S/P Primary LSTCS With IUD
Waiting Final Action
Indication: Empiric Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes